Subscribe to Newsletter

Biosimilars

Manufacture Biosimilars

The Good and the Bad of Biosimilars

| Sponsored by GE Healthcare

The biosimilars market is suddenly booming, but such steep competition means that only the wise will survive.

Manufacture Biosimilars

The CHO’s Over: An Inflexion Point

| Mark Emalfarb

Global healthcare costs and demands are changing, and it’s time to look beyond mammalian cell lines.

Manufacture Business Practice

Business-in-Brief

| Stephanie Vine

After many years of clinical trial failures in Alzheimer’s disease, pharma sees some positive results – although caution is recommended.

Manufacture Biosimilars

For Patients, Not Profits

| Stephanie Vine

A new not-for-profit company will manufacture important generics in the US

Business & Regulation Business Practice

Ahead of the Curve

Sitting Down With... Ajaz Hussain, President, National Institute for Pharmaceutical Technology and Education, Minnesota, USA.

Business & Regulation Biosimilars

Land of Opportunity

| Stephanie Vine

Biosimilars had their big break in the US in 2015, but three years later biosimilars are still struggling to make a mark.

Manufacture Business Practice

Biosimilar Backer

| Stephanie Vine

Sitting Down With Cyrus Krakaria, President of Biotechnology for Lupin Limited, Biotech Division, India.

Manufacture Biosimilars

Who Wants to Put Biosimilars to the Test

WHO is investigating the potential of certain biosimilars in a prequalification pilot program.

Business & Regulation Biosimilars

A New Supporter

| Stephanie Vine

Initially, The American College of Rheumatology was cautious about biosimilars, but times have changed.

Discovery & Development Biosimilars

What Regulators Want

| Bruno Speder

The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register